ES2433433T3 - Procedimiento para preparar un producto lácteo pasterizado y fermentado complementado con calcio y vitamina D - Google Patents
Procedimiento para preparar un producto lácteo pasterizado y fermentado complementado con calcio y vitamina D Download PDFInfo
- Publication number
- ES2433433T3 ES2433433T3 ES10782533T ES10782533T ES2433433T3 ES 2433433 T3 ES2433433 T3 ES 2433433T3 ES 10782533 T ES10782533 T ES 10782533T ES 10782533 T ES10782533 T ES 10782533T ES 2433433 T3 ES2433433 T3 ES 2433433T3
- Authority
- ES
- Spain
- Prior art keywords
- calcium
- vitamin
- product
- milk
- pasteurized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000011575 calcium Substances 0.000 title claims abstract description 116
- 229910052791 calcium Inorganic materials 0.000 title claims abstract description 116
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 title claims abstract description 115
- 229930003316 Vitamin D Natural products 0.000 title claims abstract description 100
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 title claims abstract description 100
- 239000011710 vitamin D Substances 0.000 title claims abstract description 100
- 235000019166 vitamin D Nutrition 0.000 title claims abstract description 100
- 229940046008 vitamin d Drugs 0.000 title claims abstract description 100
- 150000003710 vitamin D derivatives Chemical class 0.000 title claims abstract description 99
- 238000000034 method Methods 0.000 title claims description 38
- 235000021001 fermented dairy product Nutrition 0.000 title description 4
- 235000013336 milk Nutrition 0.000 claims abstract description 24
- 210000004080 milk Anatomy 0.000 claims abstract description 24
- 239000008267 milk Substances 0.000 claims abstract description 23
- 235000020200 pasteurised milk Nutrition 0.000 claims abstract description 20
- 238000000855 fermentation Methods 0.000 claims abstract description 19
- 230000004151 fermentation Effects 0.000 claims abstract description 19
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 235000014048 cultured milk product Nutrition 0.000 claims abstract description 11
- 239000000654 additive Substances 0.000 claims abstract description 3
- 239000000843 powder Substances 0.000 claims abstract description 3
- 239000000047 product Substances 0.000 claims description 122
- 238000002360 preparation method Methods 0.000 claims description 19
- 235000000346 sugar Nutrition 0.000 claims description 19
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical group [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 16
- 239000001354 calcium citrate Substances 0.000 claims description 15
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 15
- 235000013618 yogurt Nutrition 0.000 claims description 15
- 235000016709 nutrition Nutrition 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 12
- 235000016127 added sugars Nutrition 0.000 claims description 12
- 150000001720 carbohydrates Chemical class 0.000 claims description 12
- 235000014633 carbohydrates Nutrition 0.000 claims description 12
- 239000011734 sodium Substances 0.000 claims description 12
- 229910052708 sodium Inorganic materials 0.000 claims description 12
- 150000008163 sugars Chemical class 0.000 claims description 12
- 239000000835 fiber Substances 0.000 claims description 11
- 239000004615 ingredient Substances 0.000 claims description 10
- 235000015140 cultured milk Nutrition 0.000 claims description 9
- 229920000881 Modified starch Polymers 0.000 claims description 8
- 239000004368 Modified starch Substances 0.000 claims description 8
- 235000019426 modified starch Nutrition 0.000 claims description 8
- 230000008569 process Effects 0.000 claims description 8
- WNLRTRBMVRJNCN-UHFFFAOYSA-L adipate(2-) Chemical compound [O-]C(=O)CCCCC([O-])=O WNLRTRBMVRJNCN-UHFFFAOYSA-L 0.000 claims description 7
- 235000013365 dairy product Nutrition 0.000 claims description 7
- 235000018102 proteins Nutrition 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 235000013399 edible fruits Nutrition 0.000 claims description 6
- 108010011485 Aspartame Proteins 0.000 claims description 5
- 244000303965 Cyamopsis psoralioides Species 0.000 claims description 5
- 102100031953 Protein 4.2 Human genes 0.000 claims description 5
- 101710196267 Protein 4.2 Proteins 0.000 claims description 5
- 239000000605 aspartame Substances 0.000 claims description 5
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims description 5
- 229960003438 aspartame Drugs 0.000 claims description 5
- 235000010357 aspartame Nutrition 0.000 claims description 5
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 claims description 4
- 235000016623 Fragaria vesca Nutrition 0.000 claims description 4
- 235000011363 Fragaria x ananassa Nutrition 0.000 claims description 4
- 229930006000 Sucrose Natural products 0.000 claims description 4
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 4
- 239000000619 acesulfame-K Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 235000013312 flour Nutrition 0.000 claims description 4
- 239000005720 sucrose Substances 0.000 claims description 4
- 244000307700 Fragaria vesca Species 0.000 claims description 3
- 102000014171 Milk Proteins Human genes 0.000 claims description 3
- 108010011756 Milk Proteins Proteins 0.000 claims description 3
- 235000019568 aromas Nutrition 0.000 claims description 3
- 235000021239 milk protein Nutrition 0.000 claims description 3
- 235000008476 powdered milk Nutrition 0.000 claims description 3
- 235000020183 skimmed milk Nutrition 0.000 claims description 3
- 239000008122 artificial sweetener Substances 0.000 claims description 2
- 235000021311 artificial sweeteners Nutrition 0.000 claims description 2
- DGQLVPJVXFOQEV-NGOCYOHBSA-N carminic acid Chemical compound OC1=C2C(=O)C=3C(C)=C(C(O)=O)C(O)=CC=3C(=O)C2=C(O)C(O)=C1[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DGQLVPJVXFOQEV-NGOCYOHBSA-N 0.000 claims description 2
- 229940114118 carminic acid Drugs 0.000 claims description 2
- 235000012730 carminic acid Nutrition 0.000 claims description 2
- 239000004106 carminic acid Substances 0.000 claims description 2
- 239000012467 final product Substances 0.000 claims description 2
- 230000014759 maintenance of location Effects 0.000 claims description 2
- 238000002156 mixing Methods 0.000 claims description 2
- 239000000110 cooling liquid Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 8
- 210000000988 bone and bone Anatomy 0.000 description 21
- 230000037081 physical activity Effects 0.000 description 15
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 12
- 230000037180 bone health Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 241000894006 Bacteria Species 0.000 description 7
- 229910052500 inorganic mineral Inorganic materials 0.000 description 7
- 239000011707 mineral Substances 0.000 description 7
- 235000020244 animal milk Nutrition 0.000 description 6
- 210000003127 knee Anatomy 0.000 description 6
- 239000004310 lactic acid Substances 0.000 description 6
- 235000014655 lactic acid Nutrition 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 235000013351 cheese Nutrition 0.000 description 5
- 238000012549 training Methods 0.000 description 5
- 235000013311 vegetables Nutrition 0.000 description 5
- 208000001132 Osteoporosis Diseases 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 241000186000 Bifidobacterium Species 0.000 description 3
- 241001134770 Bifidobacterium animalis Species 0.000 description 3
- 206010065687 Bone loss Diseases 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 235000004213 low-fat Nutrition 0.000 description 3
- 230000037323 metabolic rate Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000011164 ossification Effects 0.000 description 3
- 230000004044 response Effects 0.000 description 3
- 230000000284 resting effect Effects 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 241001608472 Bifidobacterium longum Species 0.000 description 2
- 206010017076 Fracture Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241000186660 Lactobacillus Species 0.000 description 2
- 240000001046 Lactobacillus acidophilus Species 0.000 description 2
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102000003982 Parathyroid hormone Human genes 0.000 description 2
- 108090000445 Parathyroid hormone Proteins 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 229940118852 bifidobacterium animalis Drugs 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 230000015271 coagulation Effects 0.000 description 2
- 238000005345 coagulation Methods 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 235000021185 dessert Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000004118 muscle contraction Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000199 parathyroid hormone Substances 0.000 description 2
- 238000009928 pasteurization Methods 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 235000013322 soy milk Nutrition 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 230000009469 supplementation Effects 0.000 description 2
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- 241000186015 Bifidobacterium longum subsp. infantis Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 240000008886 Ceratonia siliqua Species 0.000 description 1
- 235000013912 Ceratonia siliqua Nutrition 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 240000001929 Lactobacillus brevis Species 0.000 description 1
- 244000199885 Lactobacillus bulgaricus Species 0.000 description 1
- 235000013960 Lactobacillus bulgaricus Nutrition 0.000 description 1
- 244000199866 Lactobacillus casei Species 0.000 description 1
- 235000013958 Lactobacillus casei Nutrition 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 206010057249 Phagocytosis Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 101710196213 Protein 4.7 Proteins 0.000 description 1
- 244000018633 Prunus armeniaca Species 0.000 description 1
- 235000009827 Prunus armeniaca Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194020 Streptococcus thermophilus Species 0.000 description 1
- 208000009911 Urinary Calculi Diseases 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000009102 absorption Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 235000020194 almond milk Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000001195 anabolic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 description 1
- 229940004120 bifidobacterium infantis Drugs 0.000 description 1
- 229940009291 bifidobacterium longum Drugs 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 230000036765 blood level Effects 0.000 description 1
- 210000002449 bone cell Anatomy 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 239000011449 brick Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229940069978 calcium supplement Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- -1 citrate ions Chemical class 0.000 description 1
- 230000006835 compression Effects 0.000 description 1
- 238000007906 compression Methods 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000037123 dental health Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000021121 fermented vegetables Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 235000014106 fortified food Nutrition 0.000 description 1
- 229940068517 fruit extracts Drugs 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 235000006486 human diet Nutrition 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000001506 immunosuppresive effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000009191 jumping Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 229940004208 lactobacillus bulgaricus Drugs 0.000 description 1
- 229940017800 lactobacillus casei Drugs 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000010197 meta-analysis Methods 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020262 oat milk Nutrition 0.000 description 1
- 210000002990 parathyroid gland Anatomy 0.000 description 1
- 230000008782 phagocytosis Effects 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 235000020195 rice milk Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 235000020254 sheep milk Nutrition 0.000 description 1
- 230000012488 skeletal system development Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000031068 symbiosis, encompassing mutualism through parasitism Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING OR TREATMENT THEREOF
- A23C9/00—Milk preparations; Milk powder or milk powder preparations
- A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
- A23C9/13—Fermented milk preparations; Treatment using microorganisms or enzymes using additives
- A23C9/1322—Inorganic compounds; Minerals, including organic salts thereof, oligo-elements; Amino-acids, peptides, protein-hydrolysates or derivatives; Nucleic acids or derivatives; Yeast extract or autolysate; Vitamins; Antibiotics; Bacteriocins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Microbiology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Molecular Biology (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Dairy Products (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ES200901332U | 2009-09-17 | ||
| ES200901332 | 2009-09-17 | ||
| PCT/EP2010/005702 WO2011066880A2 (en) | 2009-09-17 | 2010-09-16 | Pasteurised and fermented dairy product and procedure for preparing such product |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2433433T3 true ES2433433T3 (es) | 2013-12-11 |
Family
ID=44115351
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES10782533T Active ES2433433T3 (es) | 2009-09-17 | 2010-09-16 | Procedimiento para preparar un producto lácteo pasterizado y fermentado complementado con calcio y vitamina D |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20120237635A1 (enExample) |
| EP (1) | EP2477503B1 (enExample) |
| JP (1) | JP6046490B2 (enExample) |
| CN (1) | CN102638994A (enExample) |
| AR (1) | AR078388A1 (enExample) |
| EA (1) | EA022291B1 (enExample) |
| ES (1) | ES2433433T3 (enExample) |
| MX (1) | MX2012003302A (enExample) |
| PT (1) | PT2477503E (enExample) |
| WO (1) | WO2011066880A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FI3582622T3 (fi) | 2017-02-17 | 2024-01-10 | Arla Foods Amba | Runsasproteiininen happamoitettu nestemäinen meijerituote, jolla on alentunut viskositeetti, menetelmä sen valmistamiseksi ja siihen liittyvät ainesosat |
| JP2018143162A (ja) * | 2017-03-03 | 2018-09-20 | 株式会社明治 | 撹拌型発酵乳の製造方法 |
| PL236967B1 (pl) * | 2018-01-29 | 2021-03-08 | Okregowa Spoldzielnia Mleczarska W Lowiczu | Sposób wytwarzania masła o zwiększonej zawartości witaminy D3 |
| PL236968B1 (pl) * | 2018-02-09 | 2021-03-08 | Okregowa Spoldzielnia Mleczarska W Lowiczu | Sposób wytwarzania śmietanki o zwiększonej zawartości witaminy D3 |
| WO2020054738A1 (ja) | 2018-09-10 | 2020-03-19 | 京セラ株式会社 | 推定装置、推定システム及び推定プログラム |
| CN112715658A (zh) * | 2020-12-29 | 2021-04-30 | 光明乳业股份有限公司 | 一种益于补钙的常温酸奶及其制备方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4315953A (en) * | 1978-12-15 | 1982-02-16 | International Flavors & Fragrances Inc. | Process for augmenting or enhancing the aroma or taste of raspberry flavored foodstuffs using 2,6,6-trimethylcyclohexene derivatives |
| US4737374A (en) * | 1987-05-07 | 1988-04-12 | Huber Clayton S | Soft-serve frozen yogurt mixes |
| ES2036481B1 (es) * | 1991-10-25 | 1994-03-01 | Danone Sa | Nuevos productos lacteos vitaminados. |
| US5219602A (en) * | 1991-12-20 | 1993-06-15 | Kraft General Foods, Inc. | Aqueous calcium citrate compositions |
| TW323330B (enExample) * | 1994-10-17 | 1997-12-21 | Toshiba Co Ltd | |
| CN1156005A (zh) * | 1995-08-11 | 1997-08-06 | 株式会社斗农 | 乳酸菌发酵饮料的制备方法 |
| JP2001517084A (ja) * | 1997-04-01 | 2001-10-02 | ザ プロクター アンド ギャンブル カンパニー | カルシウムを補足したヨーグルトおよびヨーグルトを含有する食品および飲料 |
| US5820903A (en) * | 1997-06-30 | 1998-10-13 | General Mills, Inc. | Calcium fortified yogurt and methods of preparation |
| GB9920578D0 (en) * | 1999-08-31 | 1999-11-03 | Nestle Sa | Composition for maintenance of bone or dental health or treatment of bone or dental disorders |
| US6322841B1 (en) * | 2000-02-09 | 2001-11-27 | Kraft Foods, Inc. | Cheese-like dairy gels |
| DE10021384A1 (de) * | 2000-05-03 | 2001-11-15 | Hora Reiner | Ergänzungsfutter für Haustiere |
| US6740344B2 (en) * | 2000-12-01 | 2004-05-25 | General Mill, Inc. | Calcium fortified products and methods of preparation |
| JP2004215505A (ja) * | 2003-01-09 | 2004-08-05 | Kyodo Milk Industry Co Ltd | 低ｇｉヨーグルトの製造方法 |
| US7323201B2 (en) * | 2004-06-08 | 2008-01-29 | Tate & Lyle Ingredients Americas, Inc. | Highly soluble form of tricalcium citrate, and methods of its making and use |
| FI120616B (fi) * | 2005-02-18 | 2009-12-31 | Valio Oy | Vähäenergiainen, runsaasti kalsiumia sisältävä, rasvaton maitojuoma ja menetelmä sen valmistamiseksi |
| WO2007095425A1 (en) * | 2006-02-13 | 2007-08-23 | Mcneil Nutritionals, Llc | Lactose-reduced dairy compositions and related methods |
| AU2007217851A1 (en) * | 2006-02-21 | 2007-08-30 | Nutrijoy, Inc. | Food and beverage products with improved taste impressions |
-
2010
- 2010-09-16 EP EP10782533.3A patent/EP2477503B1/en not_active Revoked
- 2010-09-16 MX MX2012003302A patent/MX2012003302A/es active IP Right Grant
- 2010-09-16 EA EA201290153A patent/EA022291B1/ru not_active IP Right Cessation
- 2010-09-16 PT PT107825333T patent/PT2477503E/pt unknown
- 2010-09-16 WO PCT/EP2010/005702 patent/WO2011066880A2/en not_active Ceased
- 2010-09-16 ES ES10782533T patent/ES2433433T3/es active Active
- 2010-09-16 US US13/496,261 patent/US20120237635A1/en not_active Abandoned
- 2010-09-16 JP JP2012529159A patent/JP6046490B2/ja active Active
- 2010-09-16 CN CN2010800487879A patent/CN102638994A/zh active Pending
- 2010-09-17 AR ARP100103394A patent/AR078388A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN102638994A (zh) | 2012-08-15 |
| AR078388A1 (es) | 2011-11-02 |
| EA022291B1 (ru) | 2015-12-30 |
| EP2477503B1 (en) | 2013-07-31 |
| US20120237635A1 (en) | 2012-09-20 |
| PT2477503E (pt) | 2013-10-31 |
| MX2012003302A (es) | 2012-07-23 |
| WO2011066880A2 (en) | 2011-06-09 |
| JP2013505006A (ja) | 2013-02-14 |
| JP6046490B2 (ja) | 2016-12-14 |
| WO2011066880A8 (en) | 2012-01-26 |
| EP2477503A2 (en) | 2012-07-25 |
| EA201290153A1 (ru) | 2012-11-30 |
| WO2011066880A3 (en) | 2011-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| O’Brien et al. | The effects of postexercise consumption of a kefir beverage on performance and recovery during intensive endurance training | |
| ES2433433T3 (es) | Procedimiento para preparar un producto lácteo pasterizado y fermentado complementado con calcio y vitamina D | |
| ES2550321T3 (es) | Micelas de proteína de suero para aumentar la masa muscular y el rendimiento | |
| JP2019080582A (ja) | 米タンパク質補助食品 | |
| EP3442549A1 (en) | Bifidobacteria for increasing lean body mass | |
| AU2014217763B2 (en) | Food composition and its use | |
| TW201635909A (zh) | 疲勞改善劑 | |
| JPWO2018164251A1 (ja) | 体力向上用組成物 | |
| JP7093262B2 (ja) | 高強度運動による疲労軽減・回復用組成物 | |
| Pour et al. | From Gut to Skeletal Muscle: Synergistic Effects of Probiotics and Spirulina Supplementation on Soccer Players’ Performance and Body Composition | |
| PT118475B (pt) | Composição e suplemento alimentar que compreende proteína de ervilha amarela | |
| Bartl et al. | A Step-by-Step Programme for Healthy Bones | |
| SHOULD et al. | The Vital Science Blog Starting Living Your Best | |
| Fat et al. | 100% Whey Protein Isolate–Vanilla | |
| BR102019004295A2 (pt) | iogurte adicionado de erva-mate peneirada, refinada ou ultra refinada | |
| WO2020058544A1 (es) | Producto lácteo fermentado fuente de fibra y probióticos con mermelada vegetal | |
| Ralf Jäger et al. | The Gut-Muscle-Axis Probiotics Flex Their Muscles in Sports Nutrition | |
| Davison | Sports Nutrition and Dairy Products | |
| Garth | Winter wellness | |
| SHIREESHA | DEVELOPMENT OF SYMBIOTIC YOGHURT FOR ELDERLY PEOPLE | |
| Louw | When the body needs calcium | |
| Singh | Development of Low-Fat Frozen Yoghurt with Incorporation of Different Fruits | |
| Bartl et al. | Prevention of Osteoporosis | |
| BR102016018766A2 (pt) | Produção de iogurte com adição de cogumelo | |
| BR102016009880A2 (pt) | Dairy product composition, manufacturing and final product process |